Burden of Herpes Zoster in selected immunocompromised populations in the German Pharmacoepidemiological Research Database (GePaRD)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/17403
• EU PAS number:
  EUPAS17402
• Study ID:
  17403
• Official title and acronym:
  Burden of Herpes Zoster in selected immunocompromised populations in the German Pharmacoepidemiological Research Database (GePaRD)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Based on data from statutory health insurance providers, the study investigates the incidence of herpes zoster in patients with different severities of immunosuppression. Besides, frequencies of complications and different aspects of healthcare resource utilisation are examined for herpes zoster patients stratified by severity of immunosuppression.
• Study status:
  Finalised

Research institution and networks

Institutions

Leibniz Institute for Prevention Research and Epidemiology - BIPS

Germany

Study timelines

Date when funding contract was signed

Planned: 03/04/2015

Actual: 01/06/2015

Study start date

Planned: 20/07/2015

Actual: 01/12/2015

Data analysis start date

Planned: 10/08/2015

Actual: 04/01/2016

Date of final study report

Planned: 10/06/2016

Actual: 30/11/2016

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKline Biologicals S.A.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable